Proprietary AI analyst is now available
- Public Comps
- Hinge Health
Hinge Health Valuation Multiples
Discover Hinge Health's revenue and EBITDA valuation multiples and M&A history, alongside public comparables like Caris Life Sciences, Chemed, XtalPi, Brookdale Senior Living and more.
Hinge Health Overview
About Hinge Health
Hinge Health Inc is a technology platform for individuals seeking to treat and prevent joint and muscle pain. Through a combination of AI-powered motion tracking technology, the Company’s platform helps members address musculoskeletal (MSK) conditions, enables improved member outcomes and supports cost reductions for its clients. The Company’s clients are self-insured employers.
Founded
2016
HQ

Employees
N/A
Website
Financials (LTM)
EV
$5B
Valuation Multiples
Start free trialHinge Health Financials
Hinge Health reported last 12-month revenue of $690M and EBITDA of $163M.
In the same LTM period, Hinge Health generated $575M in gross profit, $163M in EBITDA, and had net loss of ($226M).
Revenue (LTM)
Hinge Health P&L
In the most recent fiscal year, Hinge Health reported revenue of $588M and EBITDA of $121M.
Hinge Health is unprofitable as of last fiscal year, with gross margin of 80%, EBITDA margin of 21%, and net margin of (90%).
Financial data powered by Morningstar, Inc.
Hinge Health Stock Performance
Hinge Health has current market cap of $5B, and enterprise value of $5B.
Market Cap Evolution
Hinge Health's stock price is $65.34.
Hinge Health share price increased by 16.2% in the last 30 days, and by 26.3% in the last year.
Hinge Health has an EPS (earnings per share) of $-6.83.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $5B | $5B | 0.0% | 16.2% | 69.5% | 26.3% | $-6.83 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialHinge Health Valuation Multiples
Hinge Health trades at 7.2x EV/Revenue multiple, and 30.3x EV/EBITDA.
EV / Revenue (LTM)
Hinge Health Financial Valuation Multiples
As of June 15, 2026, Hinge Health has market cap of $5B and EV of $5B.
Hinge Health has a P/E ratio of (22.4x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Hinge Health Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Hinge Health Margins & Growth Rates
Hinge Health grew revenue by 38% and EBITDA by 77% in the last fiscal year.
In the most recent fiscal year, Hinge Health reported gross margin of 80%, EBITDA margin of 21%, and net margin of (90%).
Hinge Health Margins
Hinge Health Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Hinge Health Operational KPIs
Hinge Health's Rule of 40 is 64% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Hinge Health's Rule of X is 122% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Hinge Health Competitors
Hinge Health competitors include Caris Life Sciences, Chemed, XtalPi, Brookdale Senior Living, National Healthcare Corp, Privia Health, Emeis, Clover Health, Extendicare and Dian Diagnostics Group.
Most Hinge Health public comparables operate across Long-Term Care and Health Data & Analytics.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 5.8x | 5.2x | 34.0x | 32.5x | |||
| 2.3x | 2.2x | 12.6x | 12.1x | |||
| 24.4x | 22.0x | 75.2x | (556.6x) | |||
| 2.6x | 2.7x | 18.5x | 17.6x | |||
| 1.9x | - | 13.4x | - | |||
| 1.2x | 1.1x | 20.3x | 18.6x | |||
| 1.8x | 1.8x | 12.6x | 12.1x | |||
| 1.1x | 0.9x | 99.6x | 56.8x | |||
This data is available for Pro users. Sign up to see all Hinge Health competitors and their valuation data. Start Free Trial | ||||||
Hinge Health VC Funding History
Before going public, Hinge Health raised $1B in total equity funding, across 8 rounds.
Last private valuation of Hinge Health was $6B, after raising $400M in October 2021 from Coatue, IP Group, TCV, and 1 other investor.
Hinge Health Funding Rounds
Acquisitions by Hinge Health
Hinge Health has acquired 2 companies to date.
Last acquisition by Hinge Health was on September 17th 2021. Hinge Health acquired wrnch for undisclosed valuation.
Latest Acquisitions by Hinge Health
| Description | wrnch is a Montréal-headquartered computer vision company specializing in real-time human pose estimation for AR applications. Its SDK powers interactive fitness mirrors and retail try-on experiences for clients in consumer electronics. Incubated by TandemLaunch, the firm delivers edge-deployable AI models trained on diverse datasets. | ENSO is a US-based medical device company offering an opioid-free wearable for chronic and acute pain relief. The FDA-cleared device delivers patented electrical stimulation via app control to relax muscles and calm nerves, outperforming Vicodin in clinical trials. Used at over 100 centers including Stanford, Harvard, and Cedars-Sinai, it gains coverage from VA hospitals and workers' compensation plans, with commercial insurance expected soon. Targeting 1.5 billion chronic pain sufferers globally, ENSO devices ship to patients nationwide. |
| HQ Country | ||
| HQ City | Montreal | San Francisco, CA |
| Deal Date | 17 Sep 2021 | 9 Mar 2021 |
| Valuation | undisclosed | undisclosed |
| EV/Revenue | ||
| EV/EBITDA | ||
This data is available for Pro users. Sign up to see all Hinge Health acquisitions and their M&A valuation multiples. Start Free Trial | ||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Hinge Health
| When was Hinge Health founded? | Hinge Health was founded in 2016. |
| Where is Hinge Health headquartered? | Hinge Health is headquartered in United States. |
| Who is the CEO of Hinge Health? | Hinge Health's CEO is Daniel Perez. |
| Is Hinge Health publicly listed? | Yes, Hinge Health is a public company listed on NYSE. |
| What is the stock symbol of Hinge Health? | Hinge Health trades under HNGE ticker. |
| When did Hinge Health go public? | Hinge Health went public in 2025. |
| Who are competitors of Hinge Health? | Hinge Health main competitors include Caris Life Sciences, Chemed, XtalPi, Brookdale Senior Living, National Healthcare Corp, Privia Health, Emeis, Clover Health, Extendicare, Dian Diagnostics Group. |
| What is the current market cap of Hinge Health? | Hinge Health's current market cap is $5B. |
| What is the current revenue of Hinge Health? | Hinge Health's last 12 months revenue is $690M. |
| What is the current revenue growth of Hinge Health? | Hinge Health revenue growth (NTM/LTM) is 30%. |
| What is the current EV/Revenue multiple of Hinge Health? | Current revenue multiple of Hinge Health is 7.2x. |
| What is the current EBITDA of Hinge Health? | Hinge Health's last 12 months EBITDA is $163M. |
| What is Hinge Health's EBITDA margin? | Hinge Health's last 12 months EBITDA margin is 24%. |
| What is the current EV/EBITDA multiple of Hinge Health? | Current EBITDA multiple of Hinge Health is 30.3x. |
| What is the current FCF of Hinge Health? | Hinge Health's last 12 months FCF is $217M. |
| What is Hinge Health's FCF margin? | Hinge Health's last 12 months FCF margin is 31%. |
| What is the current EV/FCF multiple of Hinge Health? | Current FCF multiple of Hinge Health is 22.8x. |
| How many companies Hinge Health has acquired to date? | As of June 2026, Hinge Health has acquired 2 companies. |
| What was the largest acquisition by Hinge Health? | None of the M&A deals Hinge Health has completed have disclosed valuations. |
| What companies Hinge Health acquired? | Hinge Health acquired ENSO and wrnch. |
| In how many companies Hinge Health has invested to date? | Hinge Health hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Hinge Health
Lists including Hinge Health
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

